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Abstract
The retinoids, the natural or synthetic derivatives of Vitamin A (retinol), are essential for the normal development of prostate
and have been shown to modulate prostate cancer progression in vivo as well as to modulate growth of several prostate
cancer cell lines. 9-cis-retinoic acid and all-trans-retinoic acid are the two most important metabolites of retinol. Gap
junctions, formed of proteins called connexins, are ensembles of intercellular channels that permit the exchange of small
growth regulatory molecules between adjoining cells. Gap junctional communication is instrumental in the control of cell
growth. We examined the effect of 9-cis-retinoic acid and all-trans retinoic acid on the formation and degradation of gap
junctions as well as on junctional communication in an androgen-responsive prostate cancer cell line, LNCaP, which
expressed retrovirally introduced connexin32, a connexin expressed by the luminal cells and well-differentiated cells of
prostate tumors. Our results showed that 9-cis-retinoic acid and all-trans retinoic acid enhanced the assembly of connexin32
into gap junctions. Our results further showed that 9-cis-retinoic acid and all-trans-retinoic acid prevented androgen-
regulated degradation of gap junctions, post-translationally, independent of androgen receptor mediated signaling. Finally,
our findings showed that formation of gap junctions sensitized connexin32-expressing LNCaP cells to the growth modifying
effects of 9-cis-retinoic acid, all-trans-retinoic acid and androgens. Thus, the effects of retinoids and androgens on growth
and the formation and degradation of gap junctions and their function might be related to their ability to modulate
prostate growth and cancer.
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Introduction
Retinoids, the natural or synthetic derivatives of vitamin A,
regulate not only embryonic development but also organogenesis
in adult tissues [1]. A requirement for vitamin A for proliferation,
differentiation has been demonstrated in many studies in which a
deficiency of this vitamin resulted in multiple developmental
defects [1–3]. All trans-retinoic acid (ATRA) and 9-Cis-Retinoic
Acid (9-CRA) are the two most important metabolites of vitamin A
(retinol) with diverse physiological functions [1]. Retinoids are
members of the nuclear-receptor superfamily of transcription
factors and exert their pleiotropic effects by regulating the
expression of several target genes [3–5]. There are six retinoid
receptors, namely RAR a, b, c, which bind to ATRA and 9-CRA,
and RXR a, b, c, which bind only to 9-CRA. Retinoid initiated
signaling regulates several homeostatic control mechanisms during
embryonic development and in adult tissues and one such control
mechanism likely to be regulated is the direct cell-cell communi-
cation mediated by a special class of cell junctions called gap
junctions (GJs) [6–8]. Gap junctions are ensembles of intercellular
channels that signal by permitting the direct exchange of small
molecules (#1500 Da) between contiguous cells. The constituent
proteins of GJs, called connexins (Cxs), are coded by 21 genes,
which have been designated according to their molecular mass [9].
Cell-cell channels are bicellular structures formed by the collabo-
rative effort of two cells. To form a GJ cell-cell channel, Cxs first
oligomerize as hexamers, called connexons, which dock with the
connexons displayed on contiguous cells [10]. Multiple lines of
evidence lends credence to the notion that gap junctional
communication is an important homeostatic control mechanism
for regulating cell growth and differentiation. For example, impaired
Cx expression, or loss of function, has been implicated in the
pathogenesis of several types of cancers, and mutations in several Cx
genes have been detected in genetic disorders characterized by
aberrant cellular proliferation and differentiation [8,10–12]
Our previous studies showed that prostate luminal cells
expressed Cx32 and its expression coincided with the acquisition
of the differentiated state of these cells [13,14]. We showed that
progression of prostate cancer (PCA) from an androgen-dependent
state to an invasive, androgen-independent state was characterized
by the failure of Cx32 to assemble into GJs [14,15]. We have
further shown that reintroduction of Cx32 into androgen-
responsive human PCA cell line, LNCaP, retards cell growth in
vivo and in vitro [14,16]. Subsequently, we demonstrated that
androgens regulated the formation and degradation of GJs by
altering the expression level of Cx32, posttranslationally. In the
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endoplasmic reticulum associated degradation (ERAD) whereas in
their presence this fraction was rescued from degradation [17].
The significance of these findings is underscored by the fact that
androgens play a major role in the survival and maintenance of the
secretory (differentiation-related) function of luminal epithelial cells
of normal prostate as well as of tumor cells as androgen ablation
induces apoptosis or dedifferentiation of these cells [18,19]
Like androgens, retinoids are also essential for the normal
development of the prostate and modulate PCA progression in
certain mouse models as well as suppress the growth of androgen-
dependent and -independent human PCA cell lines. Squamous
metaplasia of the prostate was observed among the offsprings of
vitamin A-deficient [20] and RARc knock out mice [21].
Moreover, tissue-specific inactivation of RARa in prostate resulted
in multi-focal intraepithelial hyperplasia [22]. Epidemiological
studies have shown that decreased vitamin A serum levels increase
PCA incidence and progression, and that restoration of retinoid
levels might have a role in the reversal of the malignant phenotype
[23,24]. Several studies, including ours, have shown that the
ability of retinoids to suppress tumor cell growth and induce
differentiation is contingent upon their ability to enhance gap
junctional communication [25–28]. Because Cx32 is expressed by
luminal epithelial cells of normal prostate where it is assembled
into GJs and by epithelial cells of prostate tumors in which it is
inefficiently assembled into GJs [13–15] and because formation of
GJs has been implicated in maintaining the polarized and
differentiated state of epithelial cells [29], we reasoned that
chemopreventive, growth inhibitory and pro-differentiating effects
of 9-CRA and ATRA might result from their ability to control
formation and degradation of GJs. Therefore, we investigated
whether the formation and degradation of GJs composed of Cx32
were regulated by 9-CRA and ATRA in human PCA cells.
Because retinoids have been shown to increase the expression of
androgen receptor (AR) in androgen-responsive human PCA cell
lines [30], we rationalized that they might modulate androgen-
regulated formation and degradation of GJs and affect growth of
androgen-responsive PCA cells that express Cx32. By using
androgen-responsive LNCaP cells, which express retrovirally
introduced Cx32 whose degradation is androgen-regulated [17],
we show that 9-CRA and ATRA, like androgens, enhance the
expression of Cx32 and its subsequent assembly into GJs.
Moreover, we further show here that in this cell culture model,
ATRA and 9-CRA prevent androgen-regulated degradation of
GJs, independent of AR mediated signaling. Finally, our findings
show that expression of Cx32 and formation of GJs sensitizes these
cells to growth modifying effects of 9-CRA, ATRA and androgens.
Materials and Methods
Cell Culture
Androgen-responsive LNCaP cells were a gift from Dr. Lin
[31]. One of the several clones of LNCaP cells expressing
retrovirally transduced rat Cx32, hereafter referred to as LNCaP-
32 cells, and one of the several control clones selected in G418
after infection with control retrovirus, hereafter referred to as
LNCaP-N cells, were isolated as described [17] and were used in
the present study along with the parental LNCaP cells, hereafter
referred to as LNCaP-P cells. LNCaP-P cells were grown in RPMI
containing 5% fetal bovine serum in an atmosphere of 5% CO2/
95% air and stock cultures were maintained weekly as previously
described. LNCaP-N and LNCaP-32 cells were maintained in
RPMI containing 5% fetal bovine serum and G418 at 200 mg/ml
as describe [17]. During the course of these studies, we used two
separate lots of fetal bovine sera obtained from Sigma and
HyClone Laboratories, with nearly similar effect on the growth of
LNCaP cells. Steroid-depleted (charcoal-stripped) serum was
obtained from HyClone Laboratories (Salt Lake City, UT). We
also used phenol red free RPMI for experiments in which
charcoal-stripped serum was used [17].
Antibodies and Immunostaining
Hybridoma M12.13 (a gift from Dr. Dan Goodenough,
Harvard University) has been described earlier [14,16,17,32,33].
Mouse anti-occludin (clone OC-3F10) was from Zymed labora-
tories Inc. (South San Francisco, CA). Rabbit anti-a-catenin,
rabbit anti-b-catenin, rabbit anti-Cx32, and mouse anti-b-actin
(clone C-15) were from Sigma (St. Louis, MO). Mouse anti-E-
cadherin, mouse anti-a-catenin, mouse anti-b-catenin antibodies
were generously provided by Drs. Johnson and Wheelock (Eppley
Institute) and have been described [17,32,33]. A rabbit polyclonal
anti-AR receptor antibody was from Santa Cruz Biotech (sc-
13062, San Diego, CA). Cells were immunostained after fixing
with 2% para-formaldehyde for 15 min as described previously
[17,32,33]. Briefly, cells (1.5610
5), seeded in six well clusters
containing glass cover slips and allowed to grow to approximately
50–70% confluence, were immunostained at room temperature
with various antibodies at appropriately calibrated dilutions.
Secondary antibodies (rabbit or mouse) conjugated with Alexa
488 and Alexa 594 were used as appropriate. Images of
immunostained cells were acquired with Leica DMRIE micro-
scope (Leica Microsystems, Wetzler, Germany) equipped with
Hamamatsu ORCA-ER CCD camera (Hamamatsu-City, Japan).
For co-localization studies, serial z-sections (0.5 mm) were collected
and analyzed using image processing software (Volocity; Improvi-
sion, Inc; Perkin Elmer).
Stock Solutions
Stock solutions of various reagents were prepared as follows: 9-
CRA and ATRA (BIOMOL, Plymouth, PA) were prepared in
ethanol at 3 mM each and stored in aliquots at 280uC protected
from light. All experiments pertaining to 9-CRA and ATRA were
performed in yellow light as described [26,27]. Stock solutions of a
synthetic androgen, mibolerone (MB), (BIOMOL), and of a
natural androgen, dihydro-testosterone (DHT), were prepared at
1 mM in ethanol and stored at 220uC in small aliquots protected
from light. They were appropriately diluted with the medium at
the time of treatment.
Androgen Depletion and Other Treatments
Cells were seeded in six well clusters containing glass cover slips
(1.5610
5 cells per well) and in 6-cm (2610
5 cells per dish) or in10-
cm dishes (3.5610
5 cells per dish) in 2, 4 and 10 ml complete
culture medium, respectively. Cells were treated when approxi-
mately 50% confluent, by replenishing with fresh medium
containing various reagents at the desired concentration added
from stock solutions so that the final concentration of the solvent
did not exceed 0.3%. To grow cells under androgen-depleted
medium, normal cell culture medium was replaced with androgen-
depleted cell culture medium (phenol red-free RPMI containing
5% charcoal-stripped serum). The controls received fresh medium
containing normal serum.
Western Blot Analysis and Detergent Solubility of
Connexin32
Cell lysis, detergent solubility assay with 1% Triton X-100 (TX-
100) and the expression level of Cx32 were analyzed by Western
Retinoids and Gap Junction Assembly
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5 LNCaP-P,
LNCaP-N and LNCaP-32 cells were seeded per 10 cm dish in
10 ml of complete medium and grown to confluence, after which
cells were lysed in buffer SSK (10 mM Tris, 1 mM EGTA, 1 mM
PMSF, 10 mM NaF, 10 mM NEM, 10 mM Na2VO4,1 0m M
iodoacetamide, 0.5% TX-100, pH 7.4) supplemented with the
protease inhibitor cocktail (Sigma, St. Louis, MO). Total,
detergent-soluble and -insoluble extracts were separated by
ultracentrifugation at 100,0006g for 60 min (35,000 rpm in
analytical Beckman ultracentrifuge; Model 17–65 using a
SW50.1 rotor). The detergent-insoluble pellets were dissolved in
buffer C (70 mM Tris/HCl, pH 6.8, 8 M urea, 10 mM NEM,
10 mM iodoacetamide, 2.5% SDS, and 0.1 M DTT). Following
normalization based on cell number, the total, TX-100-soluble
and -insoluble fractions were mixed with 46SDS-loading buffer to
a final concentration of 16and incubated at room temperature for
1 h (for Cx32) before SDS-PAGE analysis.
Communication Assays
Gap junctional communication was assayed by microinjecting
the following fluorescent tracers: Lucifer Yellow (MW 443 Da;
Lithium salt); Alexa Fluor 488 (MW 570 Da; A-10436), and
Alexa Fluor 594 (MW 760 Da; A-10438). Stock solutions of
Alexa dyes, obtained as hydrazide sodium salts from Molecular
Probes (Carlsbad, CA), were prepared in water at 10 mM. Lucifer
yellow was microinjected as 2.5% aqueous stock solution.
Eppendorf InjectMan and FemtoJet microinjection systems
(models 5271 and 5242, Brinkmann Instrument, Inc. Westbury,
NY), mounted on Leica DMIRE2 microscope as described
previously, were used to microinject fluorescent tracers. The
images of microinjected cells were captured with the aid of CCD
camera (Retiga 2000R, FAST 1394) using QCapture (British
Columbia, Canada) and stored as TIFF files. Junctional transfer of
fluorescent tracer was quantitated by scoring the number of
fluorescent cells (excluding the injected one) from the captured
TIFF images either at 1 min (Lucifer Yellow), 3 min (Alexa 488)
and 15 min ( Alexa 594) after microinjection into test cell as
described [14,17,32,34].
Colony Formation and Cell Growth Assays
Cell growth was assessed either by colony forming assay or by
counting cells as described [14,34]. For colony forming assay,
2610
3 cells were seeded in 6 cm dishes in triplicate in 3 ml culture
medium. After 24 h, one ml medium containing MB, 9-CRA and
ATRA was added to the dishes to give the desired final
concentration. Cells were grown for 3–4 weeks (with a medium
change every 4–5 days containing the appropriate concentration
of MB, DHT, 9-CRA and ATRA) when they formed visible
colonies. Colonies in dishes were fixed with 3.7% buffered
formaldehyde, stained with 0.025% solution of crystal violet in
PBS, and photographed. For measuring cell growth, 5610
4 cells
were seeded in 6 cm dishes in replicate and treated with MB, 9-
CRA and ATRA either alone or in combination as described
above. Cells were allowed to grow for 9–11 days with a medium
change at day 5. Cells were trypsinized and counted in a
hemocytometer.
Results
Retinoids Enhance Cx32 Expression Level
We used LNCaP-32 cells that express retrovirally transduced rat
Cx32 [17] because parental LNCaP-P and LNCaP-N cells are
devoid of detectable levels of known Cxs and do not form
functional GJs (See Materials and Methods). Earlier studies
showed that in LNCaP-32 cells androgens regulated the formation
and degradation of GJs by controlling the expression level of
Cx32 posttranslationally, by rescuing its ERAD-mediated degra-
dation [17]. Based on the rationale described above (see
introduction) and on our experience with other cell lines
[26,27], LNCaP-32 cells were treated with 9-CRA and ATRA
for 48 h to examine if they affect Cx32 expression level. We found
that 9-CRA and ATRA increased Cx32 expression level in a dose-
dependent manner (Figure 1, A). Significant enhancement,
however, was observed only at concentration of 1 mM or higher.
As assessed by the colony formation assay, concentrations
higher than 1 mM were toxic to these cells (data not shown) and
hence we chose 1 mM of 9-CRA and ATRA for subsequent
studies. Time course studies showed that enhancement with both
retinoids occurred as early as 24 h post-treatment and reached a
plateau at 72 h (Figure 1, B). The effect of 9-CRA and ATRA on
Cx32 expression level was comparable to that observed with a
synthetic androgen, mibolerone (MB), and was not observed
with RAR-specific ligands, 13-CRA and tetrahydrotetramethyl-
nepthalenylpropanylbenzoic acid (TTNPB), or with 4-hydroxy-
phenretinamide (4-HPR)(Figure 1 C). We also examined whether
9-CRA and ATRA increased the expression level of other
cell junction associated proteins. We found that both 9-CRA
and ATRA had no significant affect on the expression level of
adherens junction proteins E-cadherin and a- and b-catenins,
however, the expression level of tight junction associated
protein, occludin, was enhanced to some extent (Figure 1D).
Moreover, 9-CRA and ATRA neither induced the expression of
endogenous Cx32 in parental LNCaP cells nor altered the
expression level of retrovirally transcribed Cx32 mRNA in
LNCaP-32 cells as measured by semi-quantitative RT-PCR
analysis (data not shown).
Retinoids Enhance Gap Junction Assembly and
Junctional Communication
We next examined the effect of 9-CRA and ATRA on the
assembly of Cx32 into GJs and on junctional communication.
Concomitant with an increase in the expression level of Cx32, 9-
CRA and ATRA increased GJ assembly as assessed immunocy-
tochemically (Figure 2 A) and biochemically by Western blot
analysis of total and Triton X (TX)-100-insoluble extracts
[16,17,35] prepared at various times after treatment (Figure 2
B). Moreover, as shown in Table 1, enhancement of GJ assembly
was accompanied by parallel increase in junctional communica-
tion as measured by the junctional transfer of three GJ permeable
fluorescent tracers, Lucifer Yellow (MW 443), Alexa 488 (MW
570), and Alexa 594 (MW 760). For example, 9-CRA and ATRA
increased junctional transfer of Alexa 594 (MW 760) 2–3 folds
compared to controls (Table 1). Because E-cadherin has been
shown to facilitate the assembly of Cxs into GJs [32,33], and Cx
expression has been shown to facilitate the assembly of tight
junctions [29], we also examined whether 9-CRA and ATRA
increased the expression level of Cx32 and its assembly into GJs
indirectly by facilitating the assembly of other cell junctions as
assessed by the detergent-insolubility of their constituent and
associated proteins. We found that both 9-CRA and ATRA had
no significant affect on the expression level of adherens junction
protein E-cadherin, however, the assembly of tight junction
protein, occludin, but not its associated protein ZO-1, appeared to
have been enhanced (Figure 2 B). Taken together, these data
suggest that 9-CRA and ATRA, like androgens, enhance the
expression level of Cx32, and its subsequent assembly into GJs,
without significantly altering the expression of E-cadherin, which
has been shown to modulate the assembly of GJs [32,33,36,37]. As
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Cx32 and occludin into cell junctions, or vice versa, appears to be
regulated coordinately [17,29,38,39].
Retinoids Modulate Androgen-regulated Formation and
Degradation of Gap Junctions
Our previous studies showed that Cx32 was degraded upon
androgen depletion by ERAD, and that androgens enhanced GJ
formation by re-routing the ERAD-targeted pool of Cx32 to the
cell surface [17]. Prompted by the data shown in Figures 1 and 2,
we next examined the expression level of Cx32 and its junctional
and non-junctional fate upon androgen depletion in the presence
and absence of 9-CRA and ATRA. For these studies, cells were
grown in androgen-depleted (charcoal-stripped), phenol-red free
cell culture medium. Consistent with earlier studies [17], we found
that androgen depletion decreased Cx32 expression level, which
was prevented upon addition of MB and DHT (Figure 3 A).
However, we found that the decrease in the expression level of
Cx32 was also prevented when androgen-depleted medium was
replenished with 9-CRA and ATRA (Figure 3 A). Moreover,
combined treatment with MB and 9-CRA or ATRA was neither
synergistic nor additive with respect to Cx32 expression level
(Figure 3 A). To substantiate the above data, we assessed the
formation of GJs immunocytochemically (Figure 3 B), biochem-
ically by detergent insolubility assay (Figure 3 C), and functionally
by measuring the junctional transfer of Lucifer Yellow (MW
443 Da), Alexa 488 (MW 570 Da), and Alexa 594 (MW 760 Da)
(Table 2). As shown in Figure 3B, androgen depletion reduced the
number of GJs drastically as Cx32-specific immunostaining was
rarely observed at cell-cell contact areas, while GJs were readily
detected in cells when androgen-depleted medium was supple-
mented with 9-CRA and ATRA and with MB and DHT (Figure 3
B). Consistent with the immunocytochemical data, junctional
transfer of Lucifer Yellow decreased significantly upon androgen
depletion, which was prevented upon replenishing androgen-
depleted medium with MB, ATRA and 9-CRA (Table 2). The
detergent insolubility assay further corroborated the immunocy-
tochemical and junctional transfer data (Figure 3 C). As was
observed in our earlier studies, depletion of androgens had no
significant effect on the detergent solubility of E-cadherin and b-
catenin and tight junction associated protein, ZO-1 (Figure 3 C).
As a control, depletion or addition of androgens, 9-CRA and
ATRA to parental LNCaP-P and G418-resistant LNCaP-N cells
neither induced GJ assembly nor had any effect on the junctional
transfer (data not shown). Collectively, these data suggest that 9-
CRA and ATRA prevent androgen-regulated degradation of
Cx32 and enhance GJ formation in LNCaP-32 cells. Because
combined treatment with androgens and retinoids was neither
synergistic nor additive, the data further suggest that GJ formation
is enhanced by rescuing the same pool of Cx32 which is targeted
for ERAD upon androgen depletion.
Retinoids Enhance Gap Junction Formation Independent
of Androgen Receptor Function
Treatment of LNCaP cells with 9-CRA has been shown to
enhance AR expression level [30]. To test if 9-CRA and ATRA
Figure 1. Retinoids increase Cx32 expression level. Cx32-expressing LNCaP-32 cells were treated with the 9-CRA, ATRA, MB and other retinoids
as indicated. A. Dose-dependent enhancement of Cx32 expression level upon 9-CRA and ATRA treatment for 48 h. Note that significant
enhancement is observed only at concentrations above 0.5 mM. B. Kinetics of enhancement of Cx32 expression level upon treatment with 9-CRA and
ATRA (1 mM) for the indicated times. Note that enhancement is observed as early as 24 h. C. Only 9-CRA and ATRA and MB increase Cx32 expression
level. Note that RAR-specific retinoids, TTNPB (tetrahydrotetramethyl-nepthalenylpropanylbenzoic acid), and 13-CRA (13-cis-retinoic acid) and the
other unrelated retinoid,4-HPR, are ineffective. Note that MB (2.5 nM) is at least 300–500 times more potent than 9-CRA and ATRA on equimolar basis.
D. Effect of 9-CRA and ATRA on adherens and tight junction associated proteins. Expression of adherens junction associated proteins E-cadherin and
a- and b-catenins, and tight junction associated protein, occludin, was analyzed by Western blot analysis of total cell lysate (5 mg). Note that only the
expression of occludin appears to change noticeably.
doi:10.1371/journal.pone.0032846.g001
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medium, we grew LNCaP-32 cells in control, androgen-depleted,
and androgen-depleted plus 9-CRA, ATRA and MB containing
medium for 48 h. As assessed by Western blot analysis, we found
that androgen depletion reduced both the expression level of AR
and Cx32, which was prevented upon replenishment with MB,
DHT, 9-CRA and ATRA (Figure 4 A). These data raised the
possibility that 9-CRA and ATRA enhanced GJ assembly in an
AR-dependent manner — and not independently. To test this
notion, we treated LNCaP-32 cells with Casodex (Bicalutamide),
which blocks androgen action by competing with androgens for
binding to the AR and inhibiting function [40,41], and examined
the expression level of Cx32 and GJ formation upon treatment
with 9-CRA, ATRA and MB in the presence and absence of
Casodex in normal and androgen-depleted medium. Consistent
with previous studies, we found that treatment with Casodex
caused degradation of AR (Figure 4 B) as well as abolished the
effect of MB and DHT on Cx32 expression as was observed in our
earlier studies [17]. However, degradation of AR was also
observed with Casodex in the presence of 9-CRA and ATRA
both in androgen-depleted and normal medium. Despite robustly
decreasing AR expression level, we found that Casodex had no
effect on 9-CRA- and ATRA-mediated enhancement of Cx32
expression level. To substantiate that decrease and increase in
Cx32 expression was accompanied by parallel changes in GJ
formation, we examined the formation of GJs immunocytochem-
ically in Casodx-treated cells in the presence and absence of MB,
9-CRA and ATRA. GJs were not formed when cells were treated
with casodex in normal serum or in androgen-depleted medium
containing MB or DHT (Figure 5). On the other hand, we found
that GJs were abundant when cells were treated with casodex
along with 9-CRA or ATRA (Figure 5). These data suggest that
the mechanism by which 9-CRA and ATRA prevent the
degradation of Cx32 and enhance GJ formation upon androgen
depletion is independent of AR expression level and/or function
or both.
Connexin32 Expression Alters the Response of LNCaP
Cells to Growth Modulatory Effect of Retinoids and
Androgens
To test if Cx32 expression potentiates the growth inhibitory
effect of 9-CRA, ATRA and androgens, we measured cell growth
by treating LNCaP-32, along with LNCaP-P and LNCaP-N cells,
with various non-toxic concentrations of these agents. Cell growth
was determined by the colony forming assay (Figures 6 and 7) and
by counting the number of cells (Tables 3 and 4). As assessed
visually by the size of the colonies, we found that the growth of
LNCaP-32 cells was profoundly inhibited by MB, 9-CRA and
ATRA whereas the growth of LNCaP-P and LNCaP-N cells was
not substantially affected (Figure 6). We also found that while
combined treatment with MB and 9-CRA or ATRA inhibited
growth more drastically compared to treatment with either agent
alone in LNCaP-P and LNCaP-N cells, these effects were more
pronounced in LNCaP-32 cells (Figure 7). For example, in order
to see visible colonies, dishes of LNCaP-32 cells treated with MB
and 9-CRA or ATRA had to be fixed 10–13 days later compared
with the dishes of LNCaP-P and LNCaP-N cells. The data shown
in Figures 6 and 7 were substantiated by counting the number of
cells in replicate cultures in two independent experiments (Table 3
and 4). For example, the growth of LNCaP-P and LNCaP-N cells
was inhibited by only 20–25% upon treatment with 9-CRA,
ATRA and MB whereas the growth of LNCaP-32 cells was
inhibited by 40–55% (Table 3). Similarly, the growth of LNCaP-
32 cells was more profoundly inhibited with the combined
treatment with MB and 9-CRA or ATRA compared with
LNCaP-P and LNCaP-N cells (Table 4). Moreover, in agreement
with our previous findings [14], we found that LNCaP-32 cells
formed more compact colonies with smooth edges compared with
LNCaP-P and LNCaP-N cells which formed colonies with
scattered edges (Figure 8). Furthermore, we also observed that 9-
CRA and ATRA treated LNCaP-P and LNCaP-N cells became
flatter and more tightly packed compared to untreated cells and
these changes were more robustly pronounced in LNCaP-32 cells
(Figure 8). Finally, the morphological changes similar to those
observed upon treatment with 9-CRA and ATRA were not as
pronounced when cells were treated with MB (not shown)
although growth was inhibited.
Figure 2. Retinoids enhance the assembly of Cx32 into gap
junctions. A. LNCaP-32 cells, grown either in six well clusters or 10-cm
dishes, were treated with 9-CRA and ATRA for various times. Assembly
of Cx32 (green) into GJs was assessed immunocytochemically. E-
cadherin is shown in red. Note that GJ formation was enhanced with 9-
CRA and ATRA and MB treatment. B. Assembly of Cx32 into GJs, of tight
junction associated protein, occludin and ZO-1, and adherens junction
protein, E-cadherin, was assessed biochemically by TX100 insolubility
assay as described in Materials and methods. Note also that both the
total level and the detergent-insoluble fraction of Cx32 increased
significantly. Note also that the detergent-solubility of adherens
junction associated proteins, E-cadherin, is not significantly affected
whereas that of tight junction associated protein, occludin, is marginally
enhanced. In (A), the nuclei (blue) are stained with DAPI.
doi:10.1371/journal.pone.0032846.g002
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Our findings demonstrate that retinoids enhance the expression
level of Cx32 and formation of functional GJs in androgen-
responsive human PCA cell line, LNCaP, which expresses
retrovirally introduced Cx32. Earlier studies with these cells had
shown that androgens enhanced GJ formation by controlling the
expression level of Cx32 posttranslationally in a novel way — by
rescuing the ERAD-targeted pool of Cx32 and rerouting it to the
cell surface for GJ formation [17]. A key feature of our findings is
that, apart from enhancing GJ assembly in normal medium, 9-
CRA and ATRA also enhanced assembly by preventing
degradation of Cx32, which is triggered upon androgen depletion
in LNCaP-32 cells, independently of AR expression level or
function. Only the assembly of Cx32 into GJs appeared to be
significantly facilitated by 9-CRA and ATRA as neither the
assembly nor degradation of adherens junction associated proteins,
E-cadherin and a and b catenin, were significantly affected
although the assembly of tight junction associated protein,
occludin, appeared to be enhanced. The significance of these
findings is further underscored by the fact that both androgens and
retinoids have been documented to maintain the polarized and
differentiated state of epithelial cells of normal prostate and
prostatic tumors [19,42–45], and all have been shown to have
pleiotypic effects by acting as transcription factors [1,3,5,46]. Our
findings also showed that Cx32 expression potentiated the growth
inhibitory effect of androgens and retinoids in LNCaP-32 cells,
which indicates that their growth inhibitory and chemopreventive
effects in prostate might be related to their ability to induce GJ
formation.
Several independent lines of inquiry prompted us to undertake
these studies. First, the expression of Cx32 had generally been
found to coincide with the differentiated state of cells in the
prostate as well as in other well-differentiated and polarized cells of
several other organs [14,38,47–52]. Second, both androgens and
retinoids had previously been shown to affect prostate morpho-
genesis and oncogenesis in animal models and in cell lines,
including LNCaP [18,19,42–45,53–56]. Third, previous studies
had shown that retinoids enhanced GJ formation in several in vivo
and in vitro model systems, indicating that their chemopreventive
and pro-differentiating actions might be related to their ability to
enhance GJ assembly [7,25–27,57–59]. Fourth, Cx32 has been
documented to be a tumor suppressor in tissues in which it is
expressed [60–62] and it seemed reasonable that its expression and
assembly into GJs might be regulated by retinoids either alone or
in conjunction with androgens.
How might retinoids enhance GJ assembly and prevent
disassembly in LNCaP-32 cells? Our earlier studies with
LNCaP-32 cells had shown that androgen-depletion attenuated
GJ assembly by triggering the degradation of Cx32 by ERAD and
not by modulating the transcription of the endogenous Cx32 gene
or affecting Cx32 mRNA level driven by the retroviral promoter
[17]. Because 9-CRA and ATRA neither induced the expression
of the endogenous Cx32 in parental LNCaP and LNCaP-32 cells
nor affected retroviral driven Cx32 mRNA transcripts, it seems
likely that they enhanced GJ assembly by preventing the
androgen-regulated pool of Cx32, posttranslationally, both under
normal culture conditions as well as under androgen depleted
condition [17]. It is well-established that AR is degraded upon
androgen removal [63] and the expression level of AR in LNCaP
cells has been known to be enhanced by 9-CRA and ATRA [30].
Our previous studies [17] had shown that AR-mediated signaling
was the predominant factor in maintaining Cx32 expression level
and preventing its degradation, posttranslationally, under andro-
gen-depleted conditions in LNCaP-32 cells or in androgen-
containing medium in the presence of anti-androgen, Casodex,
which inhibits AR-function [64]. While our data showed that both
9-CRA and ATRA enhanced the expression level of AR under
androgen-depleted conditions (Figure 4 A), GJ assembly was also
robustly enhanced in the presence of Casodex despite low level of
AR (Figure 4 B). It is possible that under androgen-depleted
conditions, degradation of Cx32 is prevented by 9-CRA and
ATRA by modulating the expression level of AR, leading to
enhanced GJ assembly (Figure 4). However, our data also showed
that when AR function was inhibited with anti-androgen,
Casodex, androgen-mediated enhancement of Cx32 expression
was annulled in normal serum as well as in androgen-depleted
medium supplemented with MB, but the enhancement of GJ
assembly mediated by 9-CRA and ATRA was not affected despite
low AR expression. One possible explanation for these data is that
9-CRA and ATRA enhance GJ assembly by an AR-dependent
mechanism under androgen-depleted conditions by rescuing the
same pool of Cx32 which normally is ERAD targeted, yet activate
another signaling pathway to enhance GJ assembly when AR
function is inhibited by casodex under normal conditions. Further
studies are required to explore this possibility.
Cadherins have previously been shown to facilitate the
trafficking and assembly of Cxs into GJs and their loss has been
Table 1. Effect of 9-CRA, ATRA, and androgen on junctional transfer in LNCaP-32 cells.






Lucifer Yellow 1 14.564.1(14) 34.466.3(18) 24.766.5(19)c 3266.3.7(22)
2 16.163.6(17) 28.764.5(14) 22.165.1(17) 38.967.1(20)
Alexa-488 1 12.864.2(19) 24.364.7(25) 22.5.65.2(29) 30.767.1(22)
2 10.263.3 (21) 25.862.3(22) 20.264.8(26) 29.868.2(27)
Alexa-594 1 7.762.3(25) 17.162.9(25) 14.963.7(25) 14.163.9(27)
25 . 3 61.7(20) 14.864.1(22) 13.363.9(22) 15.165.7 (22)
LNCaP-32 cells, seeded in 6 cm dishes, were grown to 70% confluence. Junctional transfer was measured after microinjecting fluorescent tracers as described in
Materials and Methods.
a: The number of fluorescent cell neighbors (mean 6 SE) 1 min (Lucifer Yellow), 3 min (Alexa-488) and 15 min ( Alexa-594) after microinjection into test cell. The total
number of injection trials is shown in parentheses.
b: Cells were treated for 48 h with 9-CRA and ATRA (1 mM) and MB (2.5 nM).
doi:10.1371/journal.pone.0032846.t001
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However, our data documented that 9-CRA and ATRA had no
significant effect on the degradation of adherens junction
associated proteins E-cadherin or a and b catenins both under
normal and androgen-depleted conditions (Figures 2 and 3).
Therefore, it seems less likely that the degradation of Cx32, and
GJs composed of it, was triggered indirectly by the loss of E-
cadherin. Previous studies in other cells [29,38,39], and our earlier
studies with LNCaP-32 cells [17], had shown that the trafficking of
occludin to the cell surface and its detergent solubility was
controlled by the assembly of Cx32 into GJs as androgen-depletion
caused its internalization into intracellular stores [17]. In this
regard, it is worth noticing that 9-CRA and ATRA increased both
the total level of occludin as well as its detergent insolubility,
although not robustly, which suggests that the assembly of Cx32
and occludin might be coordinately regulated by retinoids, and
that this might be one of the mechanisms by which retinoids act as
chemopreventive agents and maintain the polarized and differen-
tiated state of epithelial cells. Further studies are required to
substantiate this notion.
A salient feature of the data presented here is that the expression
of Cx32 potentiated the growth inhibitory effect of androgens, 9-
CRA and ATRA in LNCaP-32 cells as compared with their effect
on LNCaP-P and LNCaP-N cells (Figure 6, Table 3). Moreover,
combined treatment with the androgens and 9-CRA and ATRA
was more potent than treatment with the either agent alone
Figure 3. Retinoids block androgen-regulated formation and degradation of gap junctions. LNCaP-32 cells, grown to 70% confluence
either in six well clusters or 10-cm dishes, were switched to charcoal-stripped, androgen-depleted (Strip) medium. Expression level of Cx32 and
formation of GJs were analyzed by Western blot (A) and immunocytochemical analysis (B) after 48 h in the presence and absence of 9-CRA and ATRA
(1 mM) and MB (2.5 nM) and DHT (10 nM). C. Formation of GJs was also analyzed by Western blot analysis of total, detergent-soluble and -insoluble
fractions as described in Materials and Methods. Note that Cx32 and GJs are degraded in androgen-depleted medium and degradation is blocked
upon replenishment with 9-CRA, ATRA, MB and DHT. Note also that only the expression level of Cx32 and its detergent solubility changed
significantly whereas that of E-cadhiern (E-cad), b-catenin (b-cat) and ZO-1 was not significantly affected. In (B), the nuclei (green) were stained with
DAPI. In A, 10 mg of total protein was analyzed.
doi:10.1371/journal.pone.0032846.g003
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CRA and ATRA has had complex effects on growth, with some
concentrations inhibiting growth and others enhancing growth
[66–73]. In our studies, the concentrations of MB, 9-CRA and
ATRA chosen were only marginally growth inhibitory to Cx-null
LNCaP-P and LNCaP-N cells, but were profoundly growth
inhibitory to Cx32-expressing LNCaP-32 cells. It is worth
mentioning that in agreement with our earlier studies in other
cell culture model systems [26], but in contrast to the complexity
of the effect of MB, 9-CRA and ATRA on cell growth [66–73],
these agents consistently enhanced the expression level of Cx32
and its assembly into GJs both in normal serum and under
androgen-depleted condition in LNCaP-32 cells.
What might be the possible explanation for these findings? It is
as yet unknown which signaling pathways are activated or
suppressed upon formation and degradation of GJs [8,10,74]
and how they are causally linked to the growth inhibitory effect
[28,58,59]. Because androgens, 9-CRA and ATRA also inhibited
the growth of Cx-null cells, and inhibition was potentiated upon
expression of Cx32, it seems more likely that the formation of GJs
either modulates a signaling pathway different from that activated
by androgens and 9-CRA and ATRA or amplifies a pathway(s)
activated by them or both. In previous studies we had shown that
expression of Cx32 in LNCaP cells not only inhibited growth in
vivo and in vitro but also induced differentiation as assessed by the
ability to synthesize prostatic specific antigen, which is expressed
by the well-differentiated luminal cells of the prostate [14].
Moreover, these studies also showed that serial propagation of
Cx32-expressing LNCaP sub-clones caused selection of cells in
which the capacity to assemble GJs was lost as only few sub-clones
could be established that retained the ability to form GJs and in
which the growth suppressing effect of junction formation was
compensated by other growth-modulatory mechanisms [14]. In
this regard, it is noteworthy that transient expression of Cx43 in
LNCaP cells via adenoviruses sensitizes these cells to apoptosis
induced by tumor necrosis factor a, TRAIL, and anti-Fas
antibodies to which Cx-null LNCaP cells are resistant. Because
formation of functional GJs was required for sensitization and Cx
expression had no effect on TNF-a receptor number, Wang et al.
have proposed that transmission of some small molecules from
cell-to-cell acted as an apoptotic trigger [75]. It is at present
difficult to envisage how chemopreventive, pro-differentiating and
growth-inhibitory effects of 9-CRA and ATRA are tied to the
formation of GJs as the expression of several classes of genes has
been shown to be altered by them [11,12,28,59,76,77].
The incidence of PCA escalates dramatically at ages when men
confront other competing causes of mortality. Prostate cancer is a
slow growing tumor with a long latency period and while the
incidence of histologically detectable PCA is high, the incidence of
clinically detectable disease is low and is influenced by dietary
factors [19,71,78]. Moreover, this long latency period affords
opportunities for intervention with therapies that are designed to
delay disease initiation and/or progression. Although retinoids
have been considered as one of the candidate dietary factors in
Table 2. Effect of 9-CRA, ATRA and androgen on junctional
transfer in LNCaP-32 cells under androgen-depleted
conditions.
Treatment Exp # Junctional Tracer
LY Alexa488 Alexa-594
NS 1 14.564.1(21) 27.464.7(24) 15.463.3(22)
2 16.163.6(27) 24.865.2(27) 16.166.1(18)
Strip 1 2.460.7(24) 2.160.6(24) 0(11)
21 . 8 60.6.(22) 2.860.6.(27) 0(13)
Strip+MB 1 29.46.5.7(32) 2664.1(21) 13.362.47(23)
2 32.966.3(28) 30.165.2(20) 14.463.1(19)
Strip+9-CRA 1 27.465.1(24) 29.268.1(21) 12.562.1(22)
2 33.867.4(28) 34.966.1(25) 15.964.1(18)
Strip+ATRA 1 22.463.7(23) 23.764.6(24) 13.263.3(32)
2 28.264.1(29) 28.965.7(24) 15..967.1(30)
LNCaP-32 cells, seeded in 6 cm dishes, were grown to 70% confluence, after
which they were switched to charcoal-stripped, androgen-depleted medium
(Strip) for 48 h in the presence and absence of 9-CRA, ATRA, and MB. Junctional
transfer was quantified as described in Table 1 legend and in Materials and
Methods.
doi:10.1371/journal.pone.0032846.t002
Figure 4. Effect of 9-CRA, ATRA and androgens on the
expression level of Cx32 and AR. A. LNCaP-32 cells were grown
to 70–80% confluence in 6 cm dishes. Cells were switched to charcoal-
stripped, androgen-depleted medium (ST) containing 9-CRA and ATRA
(1 mM) and MB (2.5 nM) and DHT (10 nM) for 24 h. Cells in androgen-
containing medium (NS) or androgen-depleted medium (ST) were used
as controls. Expression level of Cx32 and AR was analyzed by Western
blotting. Note that the expression level of both Cx32 and AR decreases
upon androgen depletion and the decrease is blocked upon treatment
with 9-CRA, ATRA, MB and DHT. B. LNCaP-32 cells, seeded as above,
were treated with of 9-CRA and ATRA (1 mM) and MB (2.5 nM) and DHT
(10 nM) in the presence and absence of Casodex (10 mM) in normal and
androgen-depleted medium. Expression level of Cx32 and AR was
examined after Western blotting. Note that in Casodex containing
medium, the expression level Cx32 does not decrease in the presence
of 9-CRA and ATRA (1 mM) in charcoal-stripped medium despite low
level of AR expression. This is not observed with MB and DHT.
doi:10.1371/journal.pone.0032846.g004
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controversial as both suppressive and stimulatory effects have been
reported [24,79–81]. Androgens and retinoids are required for the
maintenance of normal healthy prostate epithelium as in their
absence glandular atrophy of the prostate ensues due to massive
apoptosis of luminal epithelial cells [18,82]. Although retinoids
Figure 5. Effect of 9-CRA, ATRA, and androgens on the
formation of gap junctions in the presence and the absence
of casodex. LNCaP-32 cells, seeded in six well clusters containing glass
cover slips, were allowed to grow to 70% confluence. Cells were then
grown for additional 24 h in normal medium (NS), in charcoal-stripped,
androgen-depleted medium alone (ST), in normal serum containing
casodex (NS+CDX), and in androgen-depleted medium supplemented
with MB (ST+MB), with MB and casodex (ST+MB+CDX), with 9-CRA
(ST+CRA), 9-CRA and CDX (ST+CRA+CDX), with ATRA (ST+ATRA), and
with ATRA and CDX (ST+ATRA+CDX). Degradation and subcellular
localization of Cx32 were analyzed immunocytochemically as described
in Materials and methods. Note that GJs (green) are not degraded in
cells treated with 9-CRA and ATRA both in the presence and absence of
casodex whereas they are degraded in normal serum and androgen-
depleted but MB supplemented medium containing casodex. E-
cadherin is shown in red and the nuclei (blue) were stained with DAPI.
doi:10.1371/journal.pone.0032846.g005
Figure 6. Connexin expression and junction formation accentuates the growth inhibitory effect of 9-CRA, ATRA and androgens in
LNCaP cells. LNCaP-P, LNCaP-N and LNCaP-32 cells were seeded at a clonal density in 6 cm dishes in triplicate (2610
3 cells per dish). After 24 h, cells
were treated with the indicated concentrations of 9-CRA, ATRA and MB. Cells were grown until they formed visible colonies (21 d for LNCaP-P and
LNCaP-N and 33 d for LNCaP-32). Medium was changed every 4 d. Colonies were fixed with formalin and stained with crystal violet as described in
Materials and Methods. Note that the growth of LNCaP-32 cells is profoundly inhibited upon 9-CRA, ATRA and MB treatment as colonies are barely
detectable.
doi:10.1371/journal.pone.0032846.g006
Figure 7. Connexin expression and junction formation accen-
tuates the growth inhibitory effect of 9-CRA, ATRA and
androgens in LNCaP cells. LNCaP-P, LNCAP-N and LNCaP-32 cells
were seeded at clonal density in 6 cm dishes in triplicate as described in
Figure 6 legend. After 24 h, cells were treated with 9-CRA, ATRA and MB
either alone or in combination. Cells were grown until they formed
visible colonies (21 d for LNCaP-P and LNCaP-N and 28 d for LNCaP-32).
Medium was changed every 4 d. Colonies were fixed with formalin and
stained with crystal violet as described in Materials and Methods. The
numbers on the dishes correspond to the following concentrations of
9-CRA, ATRA and MB. 1=control; 2: MB (0.5 nM); 3=9-CRA (0.5 mM); 4.
ATRA (0.5 mM); 5=MB+CRA; 6. MB+ATRA; 7=CRA+ATRA (0.5 mM);
8=MB=(1 nM). Note that the combined treatment is more potent
and that the growth of LNCaP-32 cells is more profoundly inhibited.
doi:10.1371/journal.pone.0032846.g007
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have been used as differentiating agents, their use in human
clinical trials has been hampered due to pleiotypic and toxic effects
[24,83,84]. Thus, the role of androgens and retinoids in
suppressing and facilitating PCA progression as well as in
maintaining the differentiated state of epithelial cells of normal
prostate and prostate tumors has remained enigmatic
[18,19,79,83,85]. In the light of the effects of androgens and 9-
CRA and ATRA on junction formation and growth, and because
of the potential interactions among AR and RXR receptor
pathways, an investigation into their additive and/or synergistic
effects on the assembly and disassembly of Cx32 into GJs might
shed light on the mechanism by which retinoids and androgens
affect growth, differentiation and apoptosis of normal and PCA
cells.
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